UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature reviews. Immunology, ISSN 1474-1733, 07/2009, Volume 9, Issue 7, pp. 491 - 502
Life Sciences & Biomedicine | Immunology | Science & Technology | B-Cell Maturation Antigen - immunology | Tumor Necrosis Factor Ligand Superfamily Member 13 - immunology | Tumor Necrosis Factor Receptor-Associated Peptides and Proteins - immunology | Humans | Toll-Like Receptors - immunology | Tumor Necrosis Factor Ligand Superfamily Member 13 - metabolism | Tumor Necrosis Factor Receptor-Associated Peptides and Proteins - metabolism | Transmembrane Activator and CAML Interactor Protein - metabolism | Signal Transduction - immunology | Lymphocyte Activation - immunology | Animals | B-Cell Activating Factor - metabolism | B-Cell Maturation Antigen - metabolism | B-Lymphocyte Subsets - metabolism | Autoimmunity - immunology | Immune Tolerance - immunology | B-Cell Activating Factor - immunology | B-Lymphocyte Subsets - immunology | Ligands | Toll-Like Receptors - metabolism | Transmembrane Activator and CAML Interactor Protein - immunology | Autoimmunity | Physiological aspects | B cells | Research | Tumor necrosis factor | Risk factors | Index Medicus
Journal Article
2.
Full Text
Signaling by the tumor necrosis factor receptor superfamily in B‐cell biology and disease
Immunological reviews, ISSN 0105-2896, 11/2011, Volume 244, Issue 1, pp. 115 - 133
BAFF | B cell | CD40 | BCMA | NF‐κB | TACI | NF-κB | Life Sciences & Biomedicine | Immunology | Science & Technology | Cell Proliferation | Humans | NF-kappa B - immunology | NF-kappa B - metabolism | Transmembrane Activator and CAML Interactor Protein - metabolism | Signal Transduction - immunology | CD40 Antigens - metabolism | B-Cell Activating Factor - immunology | B-Lymphocyte Subsets - immunology | CD40 Antigens - genetics | B-Cell Activation Factor Receptor - genetics | B-Lymphocytes - metabolism | B-Cell Activation Factor Receptor - immunology | B-Cell Maturation Antigen - immunology | Tumor Necrosis Factor Ligand Superfamily Member 13 - immunology | Gene Expression | Mice, Transgenic | Cell Survival - immunology | Immunity, Innate | Tumor Necrosis Factor Ligand Superfamily Member 13 - metabolism | Transmembrane Activator and CAML Interactor Protein - genetics | B-Cell Activation Factor Receptor - metabolism | Animals | B-Cell Activating Factor - metabolism | B-Cell Maturation Antigen - metabolism | B-Lymphocytes - immunology | B-Lymphocyte Subsets - metabolism | NF-kappa B - genetics | B-Cell Activating Factor - genetics | Neoplasms - immunology | Autoimmune Diseases | Tumor Necrosis Factor Ligand Superfamily Member 13 - genetics | Mice | B-Cell Maturation Antigen - genetics | Transmembrane Activator and CAML Interactor Protein - immunology | CD40 Antigens - immunology | Autoimmunity | Antigens | Tumor necrosis factor | Tumors | Necrosis | Index Medicus
Journal Article
Cancer research (Chicago, Ill.), ISSN 0008-5472, 03/2017, Volume 77, Issue 5, pp. 1097 - 1107
Life Sciences & Biomedicine | Oncology | Science & Technology | Tumor Necrosis Factor Ligand Superfamily Member 13 - immunology | Lymphoma, Large B-Cell, Diffuse - pathology | Interleukin-8 - biosynthesis | Humans | Neutrophils - immunology | Lymphoma, Large B-Cell, Diffuse - metabolism | Tumor Microenvironment - immunology | Animals | Tumor Necrosis Factor Ligand Superfamily Member 13 - biosynthesis | Lymphoma, Large B-Cell, Diffuse - immunology | Ligands | Tumor Necrosis Factor Ligand Superfamily Member 13 - genetics | Mice | Interleukin-8 - immunology | Lymphoma, Large B-Cell, Diffuse - genetics | Neutrophils - metabolism | Neutrophils - pathology | Tumor cells | Neutrophils | Leukocytes (neutrophilic) | Lymphoma | Blood | APRIL protein | Recruitment | Lymphocytes B | Tumor necrosis factor | DNA methylation | Acetylation | Chemokines | Interleukin 8 | Deoxyribonucleic acid--DNA | Tumors | Cancer | B-cell lymphoma | Index Medicus
Journal Article
Seminars in immunology, ISSN 1044-5323, 2006, Volume 18, Issue 5, pp. 263 - 275
Signaling | BAFF | B cells | Structure | Splice variants | Life Sciences & Biomedicine | Immunology | Science & Technology | B-Cell Activating Factor - physiology | Alternative Splicing | Humans | Substrate Specificity | Structure-Activity Relationship | Lymphocyte Subsets - immunology | Immunoglobulin Class Switching - physiology | Protein Kinase C-delta - antagonists & inhibitors | B-Cell Activating Factor - immunology | Tumor Necrosis Factor Ligand Superfamily Member 13 - chemistry | B-Cell Activation Factor Receptor - genetics | B-Cell Activation Factor Receptor - immunology | B-Cell Activation Factor Receptor - chemistry | Tumor Necrosis Factor Ligand Superfamily Member 13 - immunology | B-Lymphocytes - cytology | Transmembrane Activator and CAML Interactor Protein - chemistry | Signal Transduction | B-Cell Maturation Antigen - physiology | Lymphocyte Activation | B-Cell Activating Factor - chemistry | Tumor Necrosis Factor Ligand Superfamily Member 13 - physiology | Models, Molecular | B-Cell Activation Factor Receptor - physiology | Transmembrane Activator and CAML Interactor Protein - physiology | Protein Interaction Mapping | Transmembrane Activator and CAML Interactor Protein - genetics | Animals | B-Lymphocytes - immunology | B-Cell Activating Factor - genetics | NF-kappa B - physiology | Protein Conformation | Tumor Necrosis Factor Ligand Superfamily Member 13 - genetics | Mice | NF-kappa B p50 Subunit - physiology | Apoptosis - physiology | Transmembrane Activator and CAML Interactor Protein - immunology | Antigen Presentation - physiology | Index Medicus
Journal Article
5.
Full Text
Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases
Nature reviews. Rheumatology, ISSN 1759-4790, 04/2017, Volume 13, Issue 4, pp. 217 - 233
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Fas Ligand Protein - metabolism | Rheumatic Diseases - drug therapy | OX40 Ligand - metabolism | CD27 Ligand - antagonists & inhibitors | Dendritic Cells - immunology | Humans | Lymphotoxin-alpha - metabolism | Molecular Targeted Therapy | 4-1BB Ligand - antagonists & inhibitors | TNF-Related Apoptosis-Inducing Ligand - antagonists & inhibitors | CD40 Ligand - metabolism | CD27 Ligand - metabolism | Cell Death | Rheumatic Diseases - immunology | Signal Transduction | Lymphocyte Activation | Tumor Necrosis Factors - metabolism | 4-1BB Ligand - metabolism | Immune Tolerance | Tumor Necrosis Factor Ligand Superfamily Member 15 - metabolism | TNF-Related Apoptosis-Inducing Ligand - metabolism | Tumor Necrosis Factor Ligand Superfamily Member 14 - metabolism | Tumor Necrosis Factors - immunology | OX40 Ligand - antagonists & inhibitors | Cytokine TWEAK | Fas Ligand Protein - antagonists & inhibitors | Animals | Tumor Necrosis Factor Ligand Superfamily Member 15 - antagonists & inhibitors | T-Lymphocytes - immunology | Tumor Necrosis Factor Ligand Superfamily Member 14 - antagonists & inhibitors | CD40 Ligand - antagonists & inhibitors | Lymphotoxin-alpha - antagonists & inhibitors | Tumor Necrosis Factors - antagonists & inhibitors | Care and treatment | Cytokines | Tumor necrosis factor | Rheumatic diseases | Development and progression | Genetic aspects | Health aspects | Index Medicus
Journal Article